Altered ESRP2 expression has also been found in human HCC samples (93), so it is reasonable to expect that ESRP2-mediated splicing plays a role in liver disease as inflammation is a marker of progression from NAFLD to NASH (94). This evidence concerns the gene ESRP2 and hepatocellular carcinoma.